Valeant Pharmaceuticals Reports Revenue Increase for Q3

By Staff
Wednesday, October 22, 2014 12:23 AM LAVAL, Quebec—Valeant Pharmaceuticals, Inc. (NYSE/TSX: VRX) reported its total revenue for the third fiscal quarter ended Sept. 30, 2014, was $2.1 billion, up 33 percent compared to the third quarter of 2014, with the U.S. and emerging market businesses contributing strong double-digit, same-store organic growth.

New Look Closes Purchase of Greiche & Scaff

By Staff
Wednesday, October 22, 2014 12:20 AM MONTREAL— New Look Eyewear Inc. ((TSX: BCI)), the Canadian optical retailer, completed its acquisition of certain optical assets and business forming part of Optic Direct Inc, carrying on business under the Greiche & Scaff banner in Quebec.

Johnson & Johnson’s 3Q Sales Rise 5.1 Percent

By Staff
Wednesday, October 15, 2014 12:23 AM NEW BRUNSWICK, N.J.—Boosted by a strong performance by its pharmaceutical business, Johnson & Johnson (NYSE: JNJ)  yesterday reported sales of $18.5 billion for the third quarter of 2014, an increase of 5.1 percent versus third quarter 2013.

RevolutionEHR Receives Financial Investment from RevOptix, Newly Formed Private Investment Group

By Staff
Friday, October 10, 2014 12:23 AM MADISON, Wis.—Earlier this week on Wednesday, Oct. 8, 2014, optometric software provider, RevolutionEHR received a financial investment from RevOptix, a newly formed private investment group headed by executive chairman Gunnar Bjorklund.

QLT Merger With Auxilium Pharmaceuticals, Inc. Is Terminated for Superior Proposal

By Staff
Friday, October 10, 2014 12:17 AM VANCOUVER, British Columbia— QLT Inc. (Nasdaq:QLTI) (TSX:QLT) said it has been advised by Auxilium Pharmaceuticals, Inc. that Auxilium's board of directors has reviewed an offer from Endo International plc to acquire all of the issued and outstanding shares of Auxilium.

Allergan Asks Court to Block Ackman Share Vote

By Staff
Wednesday, October 08, 2014 12:23 AM IRVING, Calif.— Allergan Inc. ((NYSE: AGN), which is continuing its efforts to fend off an unsolicited, $54 billion takeover bid by Valeant Pharmaceuticals International (NYSE: VRX), the parent company of Bausch + Lomb Inc., asked a judge to block Bill Ackman’s Pershing Square from voting at a shareholder meeting scheduled for December.

ZeaVision Receives Equity Investment From DSM Venturing

By Staff
Wednesday, October 08, 2014 12:20 AM ST. LOUIS— ZeaVision Holdings, Inc., supplier of nutritional supplements for eye health, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.

Unilens Net Income Up Over 100 Percent for Q4, Up About 15 Percent for Fiscal Year 2014

By Staff
Friday, October 03, 2014 12:23 AM LARGO, Fla.—Specialty contact lens supplier, Unilens Vision Inc.’s (OTCQX: UVIC) net income increased 115.3 percent to $277,636 in the fourth quarter ended June 30, 2014, when compared with net income of $128,960 during the comparable fourth quarter period of 2013, according to operating results just released by the company.

Unilens Vision Inc. Begins Trading on OTCQX Exchange

By Staff
Friday, September 26, 2014 12:23 AM LARGO, Fla.— Unilens Vision Inc.’s (OTCQX: UVIC) common stock has been approved to trade on the OTCQX exchange, described as “the best marketplace within OTC Markets Group [OTCQX: OTCM] for established U.S. and global companies,” according to a statement released yesterday by OTC Markets Group, the operator of the OTCQX, OTCQB and OTC Pink financial marketplaces.

Allergan to Hold Special Meeting of Stockholders On Originally Scheduled Date of Dec. 18 Without Restriction

By Staff
Friday, September 19, 2014 12:26 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) announced that it has reached an agreement with Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals (NYSE: VRX) under which Allergan will hold the Special Meeting of Stockholders on the originally scheduled date of Dec.18, 2014, without restriction, and Pershing Square and Valeant will dismiss their pending litigation before the Delaware Court of Chancery.

Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting

By Staff
Monday, September 08, 2014 12:26 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) provided an update regarding the validity of the written requests from Allergan stockholders that were delivered by Pershing Square Capital Management, L.P. to request a Special Meeting of Stockholders.

The Cooper Companies Report Second Quarter Results

By Staff
Friday, September 05, 2014 12:23 AM PLEASANTON, Calif.— The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal second quarter ended April 30, 2014.

Essilor’s Revenue Rises in First-Half 2014

By Staff
Friday, August 29, 2014 12:23 AM CHARENTON-LE-PONT, France— Essilor International (Reuters: ESSI.PA) yesterday posted revenue of €2.78 billion for the six months ended June 30, 2014, up 7.9 percent from €2.58 billion in the first half of 2013.

New Look Eyewear Inc. Closes $10 Million Private Placement

By Staff
Wednesday, August 20, 2014 12:23 AM MONTREAL— New Look Eyewear Inc. (BCI) said yesterday that it has completed its previously announced "bought deal" private placement subscription receipt financing for aggregate gross proceeds of $10 million, in connection with the offering to fund the recently-announced acquisition of certain assets and business of the Grieche & Scaff banner here, as reported earlier this month by VMail.

InSite Vision Inc. Reports Q2 2014 Results

By Staff
Friday, August 15, 2014 12:23 AM ALAMEDA, Calif.— InSite Vision Incorporated (OTCBB:INSV) has reported financial results for the second quarter ended June 30, 2014.
Loading...